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Introduction 
The interest of scientific community on carbon-based smart materials is growing and, especially 
focus on graphene oxide (GO) and reduced graphene oxide (rGO).  An increasing number of bio-
applications   such as biological applications as bacterial inhibition [1], drug delivery [2] and 
photothermal therapy [3] aims the use of GO and rGO. For this reason, the methods used for the 
synthesis of graphene materials are more important because same of those procedures imply 
chemical reactions that involve hazardous and toxic reagents. In fact, the biocompatibility and 
toxicological activity of graphene-related materials is related to the methodologies employed for the 
synthesis that determine the carbon/oxygen (C/O) ratio of graphene oxide species.  
In this technical report, we focused on the synthesis of GO by means of that lead to a biocompatible 
GO form with a lower oxygen content. Thus, the synthesis of rAsGFP-rGO with the green 
fluorescent protein allowed us to obtain a biocompatible materials, without using hazardous and 
toxic reagents. This biocompatibility is the most important prerogative for the use of GO in 
biological activity assays as reported in several publications [2, 4–7]. 
 
 
Experimental procedures 
 
Experimental procedures were focused on the i) Graphene Oxide chemical synthesis; ii) reduced 
Grahene Oxide biosynthesis by means of a recombinant Green Fluorescent Protein (rAsGFP) 
expressed in Escherichia coli and produced as a highly purified protein starting from a cDNA of 
687 bp isolated from the total RNA of Anemonia sulcata tentacles [8]; iii) setting of all parameters 
for spectroscopic characterization of synthesis products.  
 
 
Graphene oxide (GO) synthesis 
 
The production of graphene oxide was carried out using a direct oxidation synthesis in protic acid 
medium, described in our previous work [9]. Briefly, expanded graphite (2.5 g) and KMnO4 (7 g) 
were introduced into a 500mL round-flask and stirred until homogeneity. The beaker was placed in 
an water-ice bath and 50 mL of concentrated sulphuric acid (98%) were added slowly (continuous 
stirring with magnetic stir bars) until a paste (green-petrol colour) was obtained. The beaker was 
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placed into a water bath at about 30 °C for 30 min to produce a spontaneous volumetric expansion. 
Next, the hydrolysis of the material was obtained adding 200 mL of distilled water very slowly in  
order to prevent an uncontrolled temperature increase. Then, the green-brownish liquid was placed 
into a silicon oil bath at 90 °C for 1 h to obtain a darker dense suspension. The suspension was 
washed by repeating centrifugation using distilled water  up to the pH reaches the neutrality. 
Eventually, the solid samples were prepared by drying in an oven at 50-60 °C overnight. 
 
 
Synthesis of reduced Graphene Oxide (rAsGFP-rGO) with rAsGFP  
 
Sample of GO (1 mg mL
‾1
, pH 7) was prepared by dispersing the solid in Milli-Q water and 
sonicating for 15 min at RT. The dispersion were stirred for 1 h at 300 rpm and centrifugated for 5 
min at 10,000 rpm before investigating the soluble fractions (Fig. 1).  
 
 
 
 
 
 
Using GO as a precursor, our rAsGFP has been used as a reductant and stabilizer. A mixed aqueous 
solution (pH 7) containing rAsGFP (1 μM) and GO (1 mg mL‾1) was sonicated for 15 min, and the 
mixture was maintained at 40 °C for 1 h. The mixture was then cooled to room temperature for a 
further 15 min. Subsequently, the mixture was stirred at 90 °C for 1 h at 400 rpm. The resulting 
black dispersion was centrifuged and then washed with water. Finally, homogenous rAsGFP-rGO 
suspension was obtained after sonication of the sample and recovery of surpernatant after 
centrifugation. 
 
Figure 1 – GO dispersion before (left) and after (right) the sonication and centrifugation. 
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Spectroscopic measurements and setting of parameters.  
Spectroscopic investigation is used to obtain information about the characteristics of the synthesis 
products as GO and rAsGFP-rGO. In particular,  UV–Vis spectra were recorded in UV2700 
spectrometer (Shimadzu) with a quartz cell with a 1 cm path length. Fourier transform infrared 
spectroscopy (FTIR) measurements were carried out in a Jasco70 FT/IR-620 spectrometer using 
KBr pellets. Photoluminescence measurements were performed on a RF 5301PC 
spectrofluorometer (Shimadzu) using 5 nm spectral slit widths for excitation and emission. 
Wavelength scanning super (about 3000 nm/min) with high sensitivity selection was selected. The 
S/N ratio of instrument is 150 or higher for the Raman line of distilled water (350 nm excitation 
wavelength, 5 nm spectral bandwidth, and 2 s response for 98% of the full scale). Wavelength 
accuracy is ±1.5 nm.  
UV–Vis spectra for GO and rAsGFP-rGO were investigated in the range 190–800 nm (Fig. 2). In 
the region from 400 to 900 nm, we did not identify absorption bands. The maximum absorbance for 
GO takes place at 236 nm with a shoulder at 300 nm. A redshift of the maximum absorbance peak 
to 247 nm is observed for rAsGFP-rGO comparing with pristine GO. 
 
 
 
  
Figure 3 shows FTIR spectra for the GO and rAsGFP-rGO. The GO spectrum exhibits the 
following characteristic bands: 3440 cm‾1 corresponds to the O–H stretching vibrations, tiny 
doublet peaks at 2920 and 2850 cm‾1 correspond to the symmetric and antisymmetric CH2 
stretching, 1710 cm‾1 is the C=O stretching, and 1630 cm‾1 is sometimes assigned to the O–H 
vibrations due to the presence of adsorbed water [10]. This doublet may correspond to keto–enol  
Figure 2 – GO and rAsGFP-rGO UV-Vis spectra. 
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tautomerism . The peak at 1384 cm‾1 can correspond to the bending vibrations of O–H or C–H. The 
peak at 1090 cm‾1 can be related to an alkoxy (R–O) or to the stretching vibration of C–OH in the 
alcoholic group.  
The interaction of GO and rAsGFP produces a different spectrum. Any variation takes place for the 
O–H stretching frequencies. At the fingerprint region, the relative intensity of keto–enol doublet is 
modified. The peak at 1710 cm‾1 is lowered with the presence of rAsGFP, while the peak at 1630 
cm‾1 retains the same position with a shoulder at 1583 cm‾1. Below 1300 cm‾1, only a broad peak is 
recorded.  
 
 
 
 
The contour plot of GO is reported in Fig. 4 using an excitation wavelength (λex) in the range 280-
400 nm. The red colour identifies the maximum GO emission (447 nm) at λex 330 nm.  
 
 
Figure 3 – GO and rAsGFP-rGO FTIR spectra. 
Figure 4 – GO photoluminescence (PL) spectra. 
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Figure 5 shows the emission spectrum of rAsGFP, GO, and rAsGFP-rGO. Concerning  rAsGFP, we 
observed an intense fluorescence emission band, once excited in the visible range (λex 470 nm). It 
presents a single main peak at 500 nm with a shoulder at about 530 nm. The liquid suspension of 
GO exhibited an equivalent PL peak centred at around at 446 nm (λex 330 nm). After the reduction 
with rAsGFP, we analysed the products of the reaction. It is evident that the reduced sample lost the 
luminescent characteristics of GO as the typical fluorescence of rAsGFP 
 
 
 
 
 
 
Conclusions 
The biosynthesis procedure used in our work by means of rAsGFP as reductant and stabilizer and 
GO as precursor, determined the formation of reduced graphene oxide as supported by 
spectroscopic measurements. In fact, the red shift of the maximum absorption peak of reduced GO 
and the disappearance of the absorption shoulder at 300 nm indicate the complete reduction and the 
removal of carbonyl functional groups (11). The interaction of rAsGFP with the alkoxy reduced and 
broadened the peak at 1090 cm
‾1
, shifting  the tautomeric equilibrium toward the enol form and 
reducing drastically the keto form [12, 13]. The partially reduced GO solution after photothermal 
reduction is a gradual shift of the PL peaks, but for longer exposure, the quenching of the PL signal 
was evident [11]. Thus, the quenching in our systems can be attributed to a massive reduction of 
GO by means of rAsGFP and a possible effect of shielding of the groups responsible for PL. 
This reduced GO will use for future biological activity assays.  
Figure 5 – PL spectra of GO (λex330 nm), rAsGFP-rGO (λex 330/470 nm), and rAsGFP (λex470 nm) . 
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